title: [Methods of development of recommendations for clinical practice (RCP) and of setting-up of a platform cancer heart vessels (PTF-CHV) in the inter3C Vaucluse-Arles].
abstract: Monitoring and prevention of cardiovascular complications of anti-neoplastic treatment are currently well known for anthracyclines and trastuzumab but remain poorly implemented. The management of cardiac and vascular side effects of targeted therapies is not codified. The purpose of the platform heart-vessel cancer is to optimize the management of such complications within a small area (Vaucluse region of Arles). The platform will offer prescribers an easily accessible database, doctors performing exams standardized monitoring forms and patients a uniform follow-up. We report here the methodology of the elaboration of recommendations for clinical practice and the ways to develop the platform. After a year of active process, an analysis of the will be performed to see opportunities for improvement and dissemination on a larger scale.
authors.affiliation: Institut Sainte-Catherine, 250, chemin de Baigne-Pieds CS 80005, 84918 Avignon cedex 9, France. Electronic address: p.debourdeau@isc84.org.
authors.forename: Philippe
authors.initials: P
authors.lastname: Debourdeau
authors.affiliation: Clinique Rhône Durance, 1750, chemin du Lavarin, 84000 Avignon, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Meuleman
authors.affiliation: Clinique Rhône Durance, 1750, chemin du Lavarin, 84000 Avignon, France.
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Dufaitre
authors.affiliation: Hôpital Saint-Éloi, 80, avenue Augustin-Fliche, 34090 Montpellier, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Laroche
authors.affiliation: Hôpital Henri-Duffaut, 305, rue Raoul-Follereau, 84902 Avignon cedex 9, France.
authors.forename: Borhane
authors.initials: B
authors.lastname: Slama
authors.affiliation: Hôpital Henri-Duffaut, 305, rue Raoul-Follereau, 84902 Avignon cedex 9, France.
authors.forename: Safia
authors.initials: S
authors.lastname: Chebrek
authors.affiliation: Hôpital Henri-Duffaut, 305, rue Raoul-Follereau, 84902 Avignon cedex 9, France.
authors.forename: Falah
authors.initials: F
authors.lastname: Aboukhoudir
authors.affiliation: Institut Sainte-Catherine, 250, chemin de Baigne-Pieds CS 80005, 84918 Avignon cedex 9, France.
authors.forename: Alice
authors.initials: A
authors.lastname: Mège
authors.affiliation: 3, avenue Alphonse-Daudet, 84130 Le Pontet, France.
authors.forename: Robert
authors.initials: R
authors.lastname: Dotigny
authors.affiliation: Institut Sainte-Catherine, 250, chemin de Baigne-Pieds CS 80005, 84918 Avignon cedex 9, France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Serin
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000009:adverse effects; D001808:Blood Vessels / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control*; D005602:France; D006321:Heart / Q000187:drug effects; D006801:Humans; D058990:Molecular Targeted Therapy / Q000009:adverse effects; D009369:Neoplasms / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D017062:Small-Area Analysis
chemical_list: D000970:Antineoplastic Agents
keywords: Antineoplastic treatment; Cardiovascular complications; Clinical care guidelines; Complication cardiovasculaire; Recommandations pour la pratique clinique; Soins de support; Supportive care; Traitement antinéoplasique